B.C. adds National Pharmacare drug plan and removes insulin pricing exception for pharmacists
Amends, effective March 1, 2026, B.C. Regs. 73/2015 – Drug Plans Regulation 344/2012 – Drug Price Regulation 222/2014 – Provider Regulation — under the Pharmaceutical Services Act
Plain-language summary · AI-assisted · not legal advice
Three linked changes take effect together. First, a new drug plan called Plan NP (National Pharmacare) is created; any person who holds a B.C. medicare card is automatically enrolled in it. Second, the existing rule that prevented pharmacists from charging beneficiaries out-of-pocket for benefits they are entitled to receive at no cost now explicitly exempts only nutritional vitamins or supplements for people with cystic fibrosis — a previous broader exception has been removed. Third, the Drug Price Regulation's carve-out that treated insulin differently from other drugs has been deleted, meaning insulin is now subject to the same pricing rules as other drugs under the regulation. Pharmacists, pharmacy operators, and drug plan administrators should review their billing and charge practices to ensure they align with the updated rules.
Who this affects: pharmacists and pharmacy operators · drug plan administrators · medicare beneficiaries in British Columbia · people living with cystic fibrosis · insulin manufacturers and distributors
Source of truth: B.C. Reg. 6/2026 on ontario.ca
Legislative text © King's Printer for Ontario. This page is not an official version of the law and is not legal advice. Verify against the official source before acting.
Get changes like this in your inbox, every Friday.